New Statistical Support for Large-Scale Clinical Trials

November 9, 2022

The Medical School Office of Research recently announced a new collaboration with the School of Public Health, allowing investigators to tap into the expertise of the Statistical Analysis of Biomedical and Educational Research (SABER) Group, a unit of the Department of Biostatistics.

SABER offers a variety of support options for investigator-initiated multi-site trials, including study design, data and project management, clinical monitoring, and development of customized apps for clinical studies. This compliments the menu of support that MICHR provides for single-site trials.

CLICK HERE for FAQs to learn more about SABER, and consider attending this upcoming informational webinar:

Statistical Resources for Multi-Site & Multidisciplinary Clinical Trials Webinar
Wednesday, November 30
CLICK HERE to register (U-M level 1 login required)
Zoom login will be emailed to registrants.

“This Medical School investment is the latest in a series of opportunities we have acted on to advance our goal to support clinical research of the highest quality and impact to improve clinical care, access, and value,” noted Steven Kunkel, Ph.D., Chief Scientific Officer and Executive Vice Dean for Research. “The expertise offered by the SABER team will help ensure that the University of Michigan will provide innovative, multi-site trials as an important component of our portfolio of Greater Discoveries.”

The transformation of clinical trials at Michigan Medicine is one of the top five goals for the Great Minds, Greater Discoveries strategic research plan.

Questions about SABER? Contact Rex Edwards, Research Manager, at